Skip to content

CONMED CNMD Work in process

Work in process at other companies

Stryker logo
StrykerSYK
$435M+9.3%
Vericel logo
VericelVCEL
$1.51M-5.0%
IAR
Integra LifeSciencesIART
$109.68M+18.4%
Solventum logo
SolventumSOLV
$222M+29.8%
Boston Scientific logo
Boston ScientificBSX
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$317.0M-1.3%
Gross profit$183.4M+3.2%
Operating income$25.4M+59.3%
Net income$13.8M+129%
EPS (diluted)$0.45+137%

Balance sheet

See full
Cash & equivalents$35.0M-1.3%
Total debt$862.6M-3.6%
Total equity$1.0B+4.1%
Total assets$2.3B+0.8%

Cash flow

See full
Operating cash flow$13.5M-67.6%
CapEx$2.9M-23.5%
Free cash flow$10.6M-72.0%

Valuation

See full
Market cap$1.04B-35.6%
Enterprise value$1.87B-24.5%
P/E19×+5.4×
P/S0.8×-0.5×

Profitability

See full
Gross margin55.2%-1.0pp
Operating margin8.2%-5.6pp
Net margin4%-5.0pp
FCF margin9%-3.5pp

Returns & leverage

See full
Return on equity5.5%-7.5pp
Debt / equity0.8×-0.1×
Current ratio2.3×0.0×

Where this comes from

Reported directly by CONMED in its filing.

Tagged under the XBRL concept us-gaap:InventoryWorkInProcessNetOfReserves.

The official record: CONMED’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about CONMED's work in process.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CONMED's work in process?
CONMED (CNMD) reported work in process of $41.18M in Q1 2026.
How has CONMED's work in process changed year-over-year?
CONMED's work in process increased by 30.2% year-over-year, from $31.64M to $41.18M.
What is the long-term trend for CONMED's work in process?
Over 5 years (2020 to 2025), CONMED's work in process has grown at a 16.0% compound annual growth rate (CAGR), from $15.86M to $33.26M.
What does work in process mean?
Partially completed goods currently in the manufacturing process, including materials, labor, and overhead costs incurred to date.